Lonza Raises 2016 Outlook as Profit Jumps on Savings, DemandBy
Company sees profit increasing by double-digit amount
First-half profit jumps 20%, beating analyst estimates
Lonza Group AG raised its guidance for 2016 after demand for the Swiss company’s drug ingredient manufacturing services grew and savings bolstered margins in the first half.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.